A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome‐Drug Interaction and Guiding Therapeutic Decisions
Advanced Materials · 2023
DOI: 10.1002/adma.202300977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2023. Verfasst von Di-Wei Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Despite the recognition that the gut microbiota acts a clinically significant role in cancer chemotherapy, both mechanistic understanding and translational research are still limited. Maximizing drug efficacy requires an in‐depth understanding of how the microbiota contributes to therapeutic responses, while microbiota modulation is hindered by the complexity of the human body. To address this issue, a 3D experimental model named engineered microbiota (EM) is reported for bridging microbiota‐drug interaction research and therapeutic decision‐making. EM can be manipulated in vitro and faithfully recapitulate the human gut microbiota at the genus/species level while allowing co‐culture with cells, organoids, and isolated tissues for testing drug responses. Examination of various clinical and experimental drugs by EM reveales that the gut microbiota affects drug efficacy through three pathways: immunological effects, bioaccumulation, and drug metabolism. Guided by discovered mechanisms, custom‐tailored strategies are adopted to maximize the therapeutic efficacy of drugs on orthotopic tumor models with patient‐derived gut microbiota. These strategies include immune synergy, nanoparticle encapsulation, and host–guest complex formation, respectively. Given the important role of the gut microbiota in influencing drug efficacy, EM will likely become an indispensable tool to guide drug translation and clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China.
- Research Center for Tissue Engineering and Regenerative Medicine & Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. Chin…
- Research Center for Tissue Engineering and Regenerative Medicine & Department of Clinical Laboratory, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, P. R. China.
- Department of Traditional Chinese Medicine, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P. R. China.
ORCID-Profile: Xian-Zheng Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zheng, D. W., Qiao, J. Y., Ma, J. C., An, J. X., Yang, C. H., Zhang, Y., Cheng, Q., Rao, Z. Y., Zeng, S. M., Wang, L., & Zhang, X. Z. (2023). A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome‐Drug Interaction and Guiding Therapeutic Decisions. Advanced Materials. https://doi.org/10.1002/adma.202300977
Vancouver
Zheng DW, Qiao JY, Ma JC, An JX, Yang CH, Zhang Y, et al. A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome‐Drug Interaction and Guiding Therapeutic Decisions. Advanced Materials. 2023. doi:10.1002/adma.202300977
BibTeX
@article{Zheng2023,
author = {Zheng, Di-Wei and Qiao, Ji-Yan and Ma, Jun-Chi and An, Jia-Xin and Yang, Chi-Hui and Zhang, Yu and Cheng, Qian and Rao, Zhi-Yong and Zeng, Si-Min and Wang, Lin and Zhang, Xian-Zheng},
title = {A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome‐Drug Interaction and Guiding Therapeutic Decisions},
journal = {Advanced Materials},
year = {2023},
doi = {10.1002/adma.202300977}
}
EUVIMED